Irure-Ventura Juan, López-Hoyos Marcos
Immunology Service, University Hospital Marqués de Valdecilla-IDIVAL, 39008, Santander, Spain.
Molecular Biology Department, University of Cantabria, 39010, Santander, Spain.
J Transl Autoimmun. 2022 Jan 11;5:100143. doi: 10.1016/j.jtauto.2022.100143. eCollection 2022.
Patients with SLE show a broad spectrum of more than 200 autoantibodies. They can be pathogenic, predictive, prognostic or even an epiphenomenon. Here, we discuss different autoantibodies that have not been included in EULAR/ACR 2019 classification criteria. Most of them have been addressed to monitor and detect disease activity and not specifically as classification criteria. Indeed, markers to assess disease activity fluctuate as compared with classification criteria and their validation is different. The development of new methods will probably bring new clinical associations and be evaluated as potential classification criteria.
系统性红斑狼疮(SLE)患者会出现超过200种种类繁多的自身抗体。它们可能具有致病性、预测性、预后性,甚至只是一种附带现象。在此,我们讨论未被纳入2019年欧洲抗风湿病联盟(EULAR)/美国风湿病学会(ACR)分类标准的不同自身抗体。其中大多数已用于监测和检测疾病活动,而非专门作为分类标准。实际上,与分类标准相比,评估疾病活动的标志物会有所波动,且其验证方式也不同。新方法的开发可能会带来新的临床关联,并作为潜在的分类标准进行评估。